# A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma

> **NCT01117298** · PHASE3 · COMPLETED · sponsor: **Sanjay Gandhi Postgraduate Institute of Medical Sciences** · enrollment: 66 (actual)

## Conditions studied

- Raynaud's Phenomenon
- Digital Ulcers
- Scleroderma

## Interventions

- **DRUG:** Tadalafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01117298
- **Lead sponsor:** Sanjay Gandhi Postgraduate Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2010-05-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01117298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01117298, "A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01117298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*